Hodgkin Lymphoma Market 10 Year Epidemiology Forecasts in 7 Major Markets

Nov 20, 2015, 00:30 ET from ReportsnReports

PUNE, India, November 20, 2015 /PRNewswire/ --

The EpiCast Report: Hodgkin's Lymphoma - Epidemiology Forecast to 2024 market research provides an overview of the risk factors and global trends of HL in the 7MM (US, France, Germany, Italy, Spain, UK and Japan).

Complete report on Hodgkin's Lymphoma Epidemiology Forecast to 2024 with 17 market data tables and 10 figures, spread across 52 pages is available at http://www.reportsnreports.com/reports/435811-epicast-report-hodgkins-lymphoma-epidemiology-forecast-to-2024.html .

This research includes a 10-year epidemiology forecast for the diagnosed incident cases of HL, segmented by age, sex, and clinical stage at diagnosis, and types (classical HL and nodular lymphocyte predominant HL, with classical HL further segmented into subtypes such as nodular sclerosis, mixed cellularity, lymphocyte-rich, and lymphocyte-depleted) in these markets. In addition, epidemiologists provide a 10-year epidemiological forecast for the five-year diagnosed prevalent cases of HL, as well as the number of HL diagnosed incident cases refractory to chemo and radiation therapy, the number of HL diagnosed incident cases who received autologous stem cell transplantation (ASCT), and HL diagnosed incident cases refractory to ASCT from 2014-2024 in these markets.

Epidemiologists forecast an increase in the diagnosed incident cases of HL in the 7MM from 23,662 diagnosed incident cases in 2014 to 28,397 diagnosed incident cases in 2024 at an Annual Growth Rate (AGR) of 2%. The increase in the diagnosed incident cases of HL was partly attributed to the moderately rising trend in the incidence of HL in the 7MM, combined with changes in the population demographics in the respective markets.

Hodgkin's lymphoma (HL), also known as Hodgkin's disease, is a type of lymphoma, a cancerous condition that affects the lymphatic system and occurs in both children and adults. HL is a rare disease that starts with abnormal growth of the white blood cells, called lymphocytes, which spreads beyond the lymphatic system and impairs the body's immune system.

Order a copy of Hodgkin's Lymphoma - Epidemiology Forecast to 2024 market research report at http://www.reportsnreports.com/purchase.aspx?name=435811 .

According to the American Cancer Society (ACS), HL can start anywhere in the lymphoid tissue of body, but quite often starts in the upper part of body with main sites in the neck, the chest, or under the arms. HL mostly spreads through lymph vessels to other lymph nodes, and in advanced stages can even invade the bloodstream and spread to other organs including the liver, lungs, and bone marrow. The most common symptoms of HL include enlarged lymph nodes under the skin of the neck, under the arm, or in the groin, fever (which can come and go over several days or weeks) without an infection; drenching night sweats, and weight loss.

Another dated but relevant market research titled EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023 provides an overview of the risk factors, comorbidities, and global and historical epidemiological trends for NHL in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast of the incident cases of follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma [DLBCL], and mantle cell lymphoma segmented by age (ages =30 years) and sex in these markets. Epidemiologists forecast an increase in the incident cases of B-cell NHL in the 6MM, from 89,455 incident cases in 2013 to 111,366 incident cases in 2023, with an annual growth rate (AGR) of 2.45%. In 2023, the US will have the highest number of incident cases of B-cell NHL, with 56,033 incident cases, followed by Germany with 17,176 incident cases, and the UK with 12,548 incident cases. Complete report on Non-Hodgkin's Lymphoma market research report of 59 pages is available at http://www.reportsnreports.com/reports/286367-epicast-report-non-hodgkins-lymphoma-epidemiology-forecast-to-2023.html .

Explore more reports on Pharmaceuticals market at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441

SOURCE ReportsnReports